Guoshan Ding
China Pharmaceutical University(CN)
Publications by Year
Research Areas
Organ Transplantation Techniques and Outcomes, Transplantation: Methods and Outcomes, Liver Disease and Transplantation, Hepatocellular Carcinoma Treatment and Prognosis, Immune Cell Function and Interaction
Most-Cited Works
- → Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma(2011)691 cited
- → MicroRNA-99a Inhibits Hepatocellular Carcinoma Growth and Correlates with Prognosis of Patients with Hepatocellular Carcinoma(2011)248 cited
- → Hepatic RIG-I Predicts Survival and Interferon-α Therapeutic Response in Hepatocellular Carcinoma(2013)231 cited
- → Hepatic IFIT3 predicts interferon‐α therapeutic response in patients of hepatocellular carcinoma(2017)74 cited
- → MiR-199a/b-5p inhibits hepatocellular carcinoma progression by post-transcriptionally suppressing ROCK1(2017)74 cited
- → Preconditioning with Physiological Levels of Ethanol Protect Kidney against Ischemia/Reperfusion Injury by Modulating Oxidative Stress(2011)66 cited
- Liver transplant recipients with portal vein thrombosis: a single center retrospective study.(2009)
- → Dendritic Cells Transduced with SOCS1 Gene Exhibit Regulatory DC Properties and Prolong Allograft Survival(2009)40 cited
- → Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development(2018)39 cited
- → Selective CD28 Blockade Results in Superior Inhibition of Donor-Specific T Follicular Helper Cell and Antibody Responses Relative to CTLA4-Ig(2017)38 cited